dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ribeiro Lima, Marcelo |
dc.contributor.author | Reyes Garau, Diana |
dc.contributor.author | Armengol, Marc |
dc.contributor.author | Fernández Serrano, Miranda |
dc.contributor.author | Roue, Gael |
dc.date.accessioned | 2020-09-14T10:28:32Z |
dc.date.available | 2020-09-14T10:28:32Z |
dc.date.issued | 2019-10-16 |
dc.identifier.citation | Ribeiro ML, Reyes-Garau D, Armengol M, Fernández-Serrano M, Roué G. Recent advances in the targeting of epigenetic regulators in b-cell non-Hodgkin lymphoma. Front Genet. 2019 Oct 16;10:986. |
dc.identifier.issn | 1664-8021 |
dc.identifier.uri | https://hdl.handle.net/11351/5256 |
dc.description | Limfoma de cèl·lules B; DNMT; EZH2 |
dc.description.sponsorship | The authors received financial support from Fondo de Investigacion Sanitaria PI15/00102 and PI18/01383, European Regional Development Fund (ERDF) "Una manera de hacer Europa" (to GR). The authors received fundings from TG Therapeutics and Celgene Corp to support researches unrelated to the present work. Funders were involved neither in the design, nor in the writing of this review. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Genetics;10 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Cèl·lules B - Tumors |
dc.subject | Genètica - Tècnica |
dc.subject | Epigenètica |
dc.subject.mesh | Lymphoma, B-Cell |
dc.subject.mesh | High-Throughput Nucleotide Sequencing |
dc.subject.mesh | Epigenesis, Genetic |
dc.subject.mesh | /drug therapy |
dc.title | Recent advances in the targeting of epigenetic regulators in b-cell non- Hodgkin lymphoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fgene.2019.00986 |
dc.subject.decs | linfoma de células B |
dc.subject.decs | secuenciación de nucleótidos de alto rendimiento |
dc.subject.decs | epigénesis genética |
dc.subject.decs | /tratamiento farmacológico |
dc.relation.publishversion | https://www.frontiersin.org/articles/10.3389/fgene.2019.00986/full |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Ribeiro ML] Laboratory of Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, Brazil. [Reyes-Garau D, Armengol D, Fernández-Serrano M, Roué G] Laboratory of Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain |
dc.identifier.pmid | 31681423 |
dc.identifier.wos | 000497436600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00102 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI18%2F01383 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |